Psychedelic Commons
ExploreMethodsAbout
Share your data

Reissig CJ

Controlled Substance Staff, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, 20910, USA.

3 papers

View
ArticlePsilocybin

Considerations in assessing the abuse potential of psychedelics during drug development.

Calderon SN, Bonson KR, Reissig CJ +3

Europe PMC2023
View
ArticlePsilocybin

High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.

Reissig CJ, Carter LP, Johnson MW +3

Europe PMC2012
View
ArticlePsychedelics

The behavioral pharmacology of hallucinogens.

Fantegrossi WE, Murnane KS, Reissig CJ

Europe PMC2008
Psychedelic Commons

The open index of psychedelic research.

Explore

All researchDatasetsTrialsShare your data

About

About the hubMethods & accuracyData sources
© 2026 Psychedelic Commons. Metadata aggregated from open sources; all rights remain with the original authors and publishers.